Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study
N Rieckmann, IM Kronish, PA Shapiro… - JAMA internal …, 2013 - jamanetwork.com
Methods. Within 1 week of ACS hospitalization, 457 patients completed the Beck
Depression Inventory and a diagnostic depression interview (see Davidson et al8 for …
Depression Inventory and a diagnostic depression interview (see Davidson et al8 for …
Depression, stress and coronary heart disease--epidemiology, prognosis and therapeutic sequelae
F Follath - Therapeutische Umschau. Revue therapeutique, 2003 - europepmc.org
Depression and coronary heart disease may be related in several ways:(1) There is
epidemiological evidence that high levels of depressive symptoms in male and female …
epidemiological evidence that high levels of depressive symptoms in male and female …
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents
HW Cohen, G Gibson, MH Alderman - The American journal of medicine, 2000 - Elsevier
PURPOSE: Several studies have found that depression and the use of antidepressant
medications are associated with an increased risk of cardiovascular disease. We assessed …
medications are associated with an increased risk of cardiovascular disease. We assessed …
Treating the depressed patient with cardiovascular problems.
SP Roose, GW Dalack - The Journal of clinical psychiatry, 1992 - europepmc.org
A multidimensional relationship exists between cardiovascular disease and affective
disorder that includes the observations that (1) there is a high rate of depression in the …
disorder that includes the observations that (1) there is a high rate of depression in the …
Selective serotonin reuptake inhibitors and myocardial infarction
Background Depression is an independent risk factor for myocardial infarction (MI).
Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of …
Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of …
Cardiovascular effects of antidepressant medications
JP Halper, JJ Mann - The British Journal of Psychiatry, 1988 - cambridge.org
Antidepressants are associated with a variety of side-effects, ranging in severity from the
merely annoying to those with significant morbidity and even potential mortality. Prominent …
merely annoying to those with significant morbidity and even potential mortality. Prominent …
Antidepressant use by class: association with major adverse cardiac events in patients with coronary artery disease
SL Grace, JR Medina-Inojosa, RJ Thomas… - Psychotherapy and …, 2018 - karger.com
Background: To assess use of antidepressants by class in relation to cardiology practice
recommendations, and the association of antidepressant use with the occurrence of major …
recommendations, and the association of antidepressant use with the occurrence of major …
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction
CB Taylor, ME Youngblood, D Catellier… - Archives of general …, 2005 - jamanetwork.com
Background Depression after myocardial infarction (MI) is associated with higher morbidity
and mortality. Although antidepressants are effective in reducing depression, their use in …
and mortality. Although antidepressants are effective in reducing depression, their use in …
Depression in the medically ill: management considerations
DL Evans, J Staab, H Ward, J Leserman… - Depression and …, 1996 - Wiley Online Library
This article reviews the management of depression in three medical conditions associated
with a high frequency of depression: coronary artery disease (CAD), cancer, and human …
with a high frequency of depression: coronary artery disease (CAD), cancer, and human …
Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease
JC Nelson, JS Kennedy, BG Pollock… - American Journal of …, 1999 - Am Psychiatric Assoc
OBJECTIVE: This study compared the efficacy, tolerability, and safety of paroxetine and
nortriptyline in depressed patients with ischemic heart disease. METHOD: After a 2-week …
nortriptyline in depressed patients with ischemic heart disease. METHOD: After a 2-week …